Step Therapy Step Therapy is a process whereby prescriptions are fil ed with an effective, but more affordable medication (Step 1). When appropriate, a more costly (Step 2) medication can be authorized if the Step 1 prescription is not effective in treating your condition. Step Therapy is used to help control Medicare Part D plan costs without jeopardizing the health of CareSource members. To see if one or more of the drugs you are taking requires Step Therapy, type the name of the drug in the Search box below. ANTI-INFLAMMATORY AGENTS - GI Drug Name: ASACOL HD, DIPENTUM Step Therapy Criteria: PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 ANTIDIABETIC AGENTS - INSULINS Drug Name: LEVEMIR, LEVEMIR FLEXPEN Step Therapy Criteria: PRIOR CLAIM FOR INSULIN GLARGINE (LANTUS OR LANTUS SOLOSTAR) ANTIDIABETIC AGENTS - MISCELLANEOUS Drug Name: INVOKANA Step Therapy Criteria: “PRIOR CLAIM FOR METFORMIN, METFORMIN ER, A SULFONYLUREA,
A COMBINATION OF SULFONYLUREA AND METFORMIN, PIOGLITAZONE, OR COMBINATION PIOGLITAZONE AND METFORMIN IN THE LAST 120 DAYS.”
BUDESONIDE - UCERIS Drug Name: UCERIS Step Therapy Criteria: PRIOR CLAIM FOR BALSALAZIDE WITHIN THE PAST 120 DAYS. BUDESONIDE-FORMOTEROL FUMARATE Drug Name: SYMBICORT Step Therapy Criteria: PRIOR CLAIM FOR ADVAIR OR DULERA WITHIN THE PAST 120 DAYS. COPD Drug Name: DALIRESP Step Therapy Criteria: “PRIOR CLAIM FOR ONE COPD AGENT (LAMA, LABA, SAMA, SAMA/
SABA) SUCH AS ATROVENT, COMBIVENT, SPIRIVA, ARCAPTA, SEREVENT, OR FORADIL WITHIN THE LAST 120 DAYS.”
GAPABENTIN SR Drug Name: GRALISE Step Therapy Criteria: PRIOR CLAIM FOR GABAPENTIN IMMEDIATE RELEASE WITHIN THE PAST GLP-1 ANALOGS Drug Name: BYDUREON, BYETTA Step Therapy Criteria: “PRIOR CLAIM FOR EITHER METFORMIN, METFORMIN ER, A SULFONYL-
UREA AGENT (E.G. GLYBURIDE, GLIPIZIDE), COMBINATION OF A SULFONYLUREA AND MET-FORMIN, A THIAZOLIDINEDIONE (E.G. PIOGLITAZONE, ROSIGLITAZONE), OR A COMBINATION THIAZOLIDINEDIONE AND METFORMIN WITHIN WITHIN THE PAST 120 DAYS.”
HYPERURICEMIC AGENTS Drug Name: ULORIC Step Therapy Criteria: PRIOR CLAIM FOR ALLOPURINOL OR COLCHICINE WITHIN THE PAST 120 KETOLIDES Drug Name: KETEK Step Therapy Criteria: PRIOR CLAIM FOR A MACROLIDE WITHIN THE PAST 120 DAYS. MULTIPLE SCLEROSIS AGENTS Drug Name: AVONEX, AVONEX ADMINISTRATION PACK, BETASERON, EXTAVIA Step Therapy Criteria: PRIOR CLAIM FOR REBIF (INTERFERON BETA-1A) OR COPAXONE (GLATI-
RAMIR ACETATE) WITHIN THE PAST 120 DAYS. “NSAIDS, CYCLOOXYGENASE INHIBITOR-TYPE” Drug Name: CELEBREX Step Therapy Criteria: PRIOR CLAIM FOR ONE (1) NON-STEROIDAL ANTI-INFLAMMATORY OPHTHALMIC ANTIHISTAMINES Drug Name: BEPREVE, PATADAY, PATANOL Step Therapy Criteria: “PRIOR CLAIM FOR OTC LORATADINE, LORATADINE D, CETIRIZINE, CETI-
RIZINE D, OR GENERIC KETOTIFEN EYE DROPS (ALAWAY) OR LEVOCETIRIZINE OR CROMOLYN SODIUM EYE DROPS WITHIN THE PAST 120 DAYS.”
RIFAXIMIN Drug Name: XIFAXAN Step Therapy Criteria: PRIOR CLAIM FOR LACTULOSE WITHIN THE PAST 120 DAYS. ROTIGOTINE Drug Name: NEUPRO Step Therapy Criteria: PRIOR CLAIM FOR IMMEDIATE RELEASE PRAMIPEXOLE OR IMMEDIATE
RELEASE ROPINIROLE WITHIN THE PAST 120 DAYS.
Active Music Therapy in Parkinson’s Disease: An Integrative Method for Motor and Emotional Rehabilitation CLAUDIO PACCHETTI, MD, FRANCESCA MANCINI, MD, ROBERTO AGLIERI, CIRA FUNDAR `O, MD, EMILIA MARTIGNONI, MD, AND GIUSEPPE NAPPI, MD Background: Modern management of Parkinson’s disease (PD) aims to obtain symptom control, to reduce clinical disability, and to improve quality of life. Mus
Platelet-rich plasma therapy PRP therapy overview Platelet-rich plasma (PRP) therapy uses the body’s own healing process to regenerate damaged tendons or liga- ments without surgery. The treatment involves an injection, or multiple injections over time, of the patient’s own blood to, a week following the PRP injection and throughout the plasma (with concentrated platelets)